Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

T-cell Lymphoma
15:48

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

New Frontline Regimens in Peripheral T-Cell Lymphoma: Brentuximab Vedotin+CHP, Lenalidomide, Alemtuzumab and Romidepsin for CHOP/CHOP-like + Disease

FEATURING Julie M. Vose
  • 187 views
  • October 18, 2019
  • 1
16:59

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Novel Approaches in Peripheral T-Cell Lymphoma Treatment: Challenges of Advancing Care, Emerging Molecular Achilles Heel, Configuring New Backbones of T-Cell Active Drugs, Immunologic Rationale

FEATURING Owen O’Connor
  • 38 views
  • October 18, 2019
09:35

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

New Insights into the Molecular Pathogenesis of Peripheral T-Cell Lymphoma

FEATURING Philippe Gaulard
  • 32 views
  • October 18, 2019
07:09

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Preliminary Results of Phase II Trial of Brentuximab Vedotin and Lenalidomide in Relapsed / Refractory Cutaneous / Peripheral T-Cell Lymphomas

FEATURING Basem William
  • 31 views
  • October 18, 2019